C12Y 304/22062
Caspase-9
Official title: Caspase-9 (3.4.22.62)
C12Y304/22062 (Caspase-9) appears on 44 US grants and 105 published applications in this corpus.
Search patents in C12Y- Granted patents
- 44
- Published applications
- 105
- Assignees
- 47
- Inventors
- 158
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 3 |
| 2015 | 4 | 11 |
| 2016 | 3 | 5 |
| 2017 | 2 | 4 |
| 2018 | 2 | 6 |
| 2019 | 5 | 8 |
| 2020 | 1 | 7 |
| 2021 | 8 | 10 |
| 2022 | 4 | 11 |
| 2023 | 4 | 5 |
| 2024 | 4 | 10 |
| 2025 | 4 | 10 |
| 2026 | 2 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genomic engineering of pluripotent cells2 Jun 2026US 12,642,852 B1Fate Therapeutics, Inc.
- DNA, expression vector, transcript, cell, pharmaceutical composition, and medicine13 Jan 2026US 12,521,450 B2Hitachi, Ltd.
- Leucine zipper-based compositions and methods of use30 Dec 2025US 12,509,498 B2Memorial Sloan Kettering Cancer Center
- Cancer vaccine19 Aug 2025US 12,390,514 B2President and Fellows of Harvard College
- Cas variants for gene editing4 Feb 2025US 12,215,365 B2President and Fellows of Harvard College
- Non-human animal, kit, and method for producing replacement organ24 Sep 2026US 2026/0283124 A1The Jikei University
- Regulated cells expressing cytokines24 Sep 2026US 2026/0286288 A1
- Cd79b humanized antibody-based chimeric antigen receptor and use thereof20 Aug 2026US 2026/0241000 A1Beijing Meikang Geno-Immune Biotechnology Co., Ltd.
- Igg derived b7-h3-specific chimeric antigen receptor (b7-h3 car) effector cells for the treatment of cd276+ tumors and autoimmune diseases23 Jul 2026US 2026/0209356 A1
- Tcd34 And Other Markers For Identification And Sorting Of Cells And For Use As In Vivo Tracking Assistant7 May 2026US 2026/0125691 A1CarryGenes Bioengineering, LLC
Most cited
By later US patents
- Methods for correcting presenilin point mutations123US 9,068,179 B1President and Fellows of Harvard College · 2015
- Methods for nucleic acid editing121US 9,840,699 B2President and Fellows of Harvard College · 2017
- Fusions of Cas9 domains and nucleic acid-editing domains74US 11,053,481 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing73US 11,124,782 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing72US 10,465,176 B2President and Fellows of Harvard College · 2019